REVISE: re-evaluating the inhibition of stress erosions in the ICU —statistical analysis plan for a randomized trial
ConclusionsThis statistical analysis plan outlines the statistical analyses of all outcomes, sensitivity analyses, and subgroup analyses. REVISE will inform clinical practice and guidelines worldwide.Trial registrationwww.ClinicalTrials.gov NCT03374800.  November 21, 2017. (Source: Trials)
Source: Trials - December 6, 2023 Category: Research Source Type: clinical trials

Prevention of Post-Cardiac Surgery Acute Kidney Injury by Proton Pump Inhibitor
Conditions: Acute Kidney Injury Interventions: Drug: Pantoprazole; Drug: Famotidine Sponsors: The University of Texas Health Science Center, Houston; Society of Cardiovascular Anesthesiologists Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2023 Category: Research Source Type: clinical trials

Proton pump inhibitors in critically ill mechanically ventilated patients with COVID-19: protocol for a substudy of the Re-EValuating the Inhibition of Stress Erosions (REVISE) Trial
DiscussionProphylactic acid suppression in invasively ventilated critically ill patients with COVID-19 infection has unknown consequences. The results of these investigations will inform practice, guidelines, and future research.Trial registrationREVISE Trial [NCT03374800 December 15, 2017], COVID-19 Cohort Study [NCT05715567 February 8, 2023]. (Source: Trials)
Source: Trials - August 30, 2023 Category: Research Source Type: clinical trials

Baduanjin Program Effect on Geriatric Functional Dyspepsia
Condition:   Functional Dyspepsia Interventions:   Behavioral: baduinjuin activities;   Other: pantoprazole Sponsor:   Cairo University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 23, 2023 Category: Research Source Type: clinical trials

Phase I Trial to Evaluate the Potential Influence of Pantoprazole on the Pharmacokinetics of Pritelivir
Condition:   HSV Infection Interventions:   Drug: Pritelivir;   Drug: ESO and pritelivir Sponsor:   AiCuris Anti-infective Cures AG Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2022 Category: Research Source Type: clinical trials